Use of a human acellular dermal wound matrix in patients with complex wounds and comorbidities

Journal of Wound Care

Volumn 24, Issue 6, 2015, Pages 261-267

  Williams, M L ^a,b   Holewinski, J E ^a,b  

^a Aventura Hospital and Medical Center   (United States)

^b BARRY UNIVERSITY   (United States)

Author keywords

Complex wounds; Diabetic foot ulcers; Human acellular dermal wound matrix; Lower extremity ulcers

Indexed keywords

ACELLULAR DERMAL MATRIX; ADULT; AGED; COMORBIDITY; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PHYSIOLOGY; PROCEDURES; SKIN TRANSPLANTATION; VERY ELDERLY; WOUND HEALING;

ACELLULAR DERMIS; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DIABETES MELLITUS; DIABETIC FOOT; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; SKIN TRANSPLANTATION; WOUND HEALING;

EID: 84931356049     PISSN: 09690700     EISSN: 20522916     Source Type: Journal    
DOI: 10.12968/jowc.2015.24.6.261     Document Type: Article

References (13)

1. Khanolkar, M.P., Bain, S.C., Stephens, J.W. The diabetic foot. QJM 2008; 101: 9, 685-695.
2. Brem, H., Sheehan, P., Boulton, A.J. Protocol for treatment of diabetic foot ulcers. Am J Surg 2004; 187: 5A, 1S-10S.
3. Harper, J.R., McQuillan, D.J. A novel regenerative tissue matrix (RTM) technology for connective tissue reconstruction. Wounds. 2007; 19: 6, 163-168.
4. Menon, N.G., Rodriguez, E.D., Byrnes, C.K. et al. Revascularization of human acellular dermis in full-thickness abdominal wall reconstruction in the rabbit model. Ann Plast Surg 2003; 50: 5, 523-527.
5. Xu, H., Wan, H., Sandor, M. et al. Host response to human acellular dermal matrix transplantation in a primate model of abdominal wall repair. Tissue Eng Part A 2008; 14: 12, 2009-2019.
6. Reyzelman, A., Crews, R.T., Moore, J.C. et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J 2009; 6: 3, 196-208.
7. Winters, C.L., Brigido, S.A., Liden, B.A. et al. A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds. Adv Skin Wound Care 2008; 21: 8, 375-381.
8. Brigido, S.A. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J 2006; 3: 3, 181-187.
9. Kirsner, R.S., Bohn, G., Driver, V.R. et al. Human acellular dermal wound matrix: evidence and experience. Int Wound J 2013. (Epub ahead of press) DOI: 10.1111/iwj.12185.
10. Veves, A., Falanga, V., Armstrong, D.G. et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001; 24: 2, 290-295.
11. Marston, W.A., Hanft, J., Norwood, P. et al. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003; 26: 6, 1701-1705.
12. Reyzelman, A.M., Bazarov, I. Human acellular dermal wound matrix for treatment of DFU: literature review and analysis. J Wound Care 2015; 24: 3, 128-134.
13. Yao, M., Fabbi, M., Hayashi, H. et al. A retrospective cohort study evaluating efficacy in high-risk patients with chronic lower extremity ulcers treated with negative pressure wound therapy. Int Wound J 2014; 11: 5, 483-488.